Most recently, it has been identified that conolidine and the above mentioned derivatives act within the atypical chemokine receptor 3 (ACKR3. Expressed in equivalent parts as classical opioid receptors, it binds to some big range of endogenous opioids. Compared with most opioid receptors, this receptor acts like a scavenger https://johnk109ked2.dgbloggers.com/profile